Plasticized Drug‐Loaded Melt Electrospun Polymer Mats: Characterization, Thermal Degradation, and Release Kinetics. Issue 4 (18th February 2014)

• Record Type: Journal Article
• Authors: Balogh, Attila; Drávavölgyi, Gábor; Faragó, Kornél; Farkas, Attila; Vigh, Tamás; Sóti, Péter Lajos; Wagner, István; Madarász, János; Pataki, Hajnalka; Marosi, György; Nagy, Zsombor Kristóf
• Is Part Of: Journal of pharmaceutical sciences. Volume 103:Issue 4(2014:Apr.)
• Page Start: 1278
• Page End: 1287
• Publication Date: 2014-02-18
• Subjects: Pharmacy -- Periodicals; 615.1
• DOI: 10.1002/jps.23904
• Languages: English
• ISSNs: 0022-3549

Abstract

<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Melt electrospinning (MES) was used to prepare fast dissolving fibrous drug delivery systems in the presence of plasticizers. This new method was found promising in the field of pharmaceutical formulation because it combines the advantages of melt extrusion and solvent‐based electrospinning. Lowering of the process temperature was performed using plasticizers in order to avoid undesired thermal degradation. Carvedilol (CAR), a poorly water‐soluble and thermal‐sensitive model drug, was introduced into an amorphous methacrylate terpolymer matrix, Eudragit® E, suitable for fiber formation. Three plasticizers (triacetin, Tween® 80, and polyethylene glycol 1500) were tested, all of which lowered the process temperature effectively. Scanning electron microscopy, X‐ray diffraction, differential scanning calorimetry, and Raman microspectrometry investigations showed that crystalline CAR turned into an amorphous form during processing and preserved it for longer time. <italic>In vitro</italic> dissolution studies revealed ultrafast drug dissolution of the fibrous samples. According to the HPLC impurity tests, the reduced stability of CAR under conditions applied without plasticizer could be avoided using plasticizers, whereas storage tests also indicated the importance of optimizing the process parameters during MES. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:1278–1287, 2014</p> </abstract>